UROsphere is an independent Contract Research company specializing in preclinical urogenital assays.
The company was founded in 2004 by Dr Philippe Lluel and Dr Stefano Palea, two senior researchers with decades of experience in large pharmaceutical companies testing and developing drug candidates for urological indications.
Through our optimized pharmacology platform, we conduct assays to investigate new therapies and combinations of existing therapies for lower urinary tract (LUTs) pathologies.
UROsphere's headquarters, laboratories and animal housing facilities are located in Toulouse, France. The company has also a representative in Gladwyne, Pennsylvania, USA.